Latest news
ICYMI: FDA Clears Medicus to Begin Gorlin Syndrome SkinJect Trial - MyChesCoMyChesCo · Mon, 03 Aug 2026 22:00:00 GMTKrystal Biotech Q2 Earnings Call Highlights - TradingViewTradingView · Mon, 03 Aug 2026 14:04:36 GMTKrystal Biotech Announces Second Quarter 2026 Financial and Operating Results - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 11:19:22 GMTKrystal Biotech Reports Strong 2Q 2026 VYJUVEK Revenue Growth and Advances Multi-Program Genetic Medicines Pipeline - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTMedicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI - Proactive financial newsProactive financial news · Sat, 01 Aug 2026 09:00:24 GMTMedicus Pharma Secures IND Authorization for Teverelix® Study in UAE - Intellectia AIIntellectia AI · Fri, 31 Jul 2026 11:54:47 GMTAbout 84 Women, Four Groups: Teverelix Endometriosis Trial - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTEXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi - SahmSahm · Fri, 31 Jul 2026 07:00:00 GMT